Ignite Creation Date:
2024-05-05 @ 5:03 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00372476
Status:
COMPLETED
Last Update Posted:
2017-02-07
First Post:
2006-09-06
Brief Title:
Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Study Overview
Official Title:
Open-label Trial of Imatinib in Combination With Vinorelbine for Patients With Advanced Breast Carcinoma ICON
Status:
COMPLETED
Status Verified Date:
2017-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
INV181
Brief Summary:
This study is designed to investigate the safety and efficacy of the combination of imatinib and vinorelbine in patients with advanced anthracycline resistant breast cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2005-001537-15 | None | None | None |